AMBASSADOR Alliance A031501: Phase III Randomized Adjuvant Study of Pembrolizumab in Muscle-Invasive and Locally Advanced Urothelial Carcinoma (MIBC) vs Observation
- Citation:
- J Clin Oncol vol 42 (suppl 4) LBA531
- Meeting Instance:
- ASCO GU 2024
- Year:
- 2024
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 4435
- Pharmas:
- Merck
- Grants:
- U10CA180821, U10CA180882;U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888 (SWOG);
- Corr. Author:
- Authors:
- Andrea B. Apolo Karla V. Ballman Guru Sonpavde Stephanie Berg William Y. Kim Rahul Parikh Min Yuen Teo Randy F. Sweis Daniel Geynisman Petros Grivas Gurkamal Chatta Zachery Roger Reichert Joseph Woong Kim Mehmet Asim Bilen Yujia Wen Olwen Hahn Susan Halabi Gabriela Perez Burbano Michael J. Morris Jonathan E. Rosenberg
- Networks:
- FL086, KANSAS, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-NC007, LAPS-NY016, LAPS-NY158, MD001
- Study
- Alliance-A031501
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: